Nickson Philip's most recent trade in Monte Rosa Therapeutics Inc was a trade of 126,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Inc | Philip Nickson | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 126,000 | 126,000 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Philip Nickson | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 28,000 | 64,000 | - | - | Common Stock | |
| Monte Rosa Therapeutics Inc | Philip Nickson | Chief Business & Legal Officer | Sale of securities on an exchange or to another person at price $ 15.17 per share. | 02 Jan 2026 | 3,155 | 60,845 | - | 15.2 | 47,861 | Common Stock |
| Monte Rosa Therapeutics Inc | Philip Nickson | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 161,000 | 161,000 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Philip Nickson | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 36,000 | 36,000 | - | - | Common Stock | |
| Monte Rosa Therapeutics Inc | Nickson Philip | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 109,000 | 109,000 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Philip Nickson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 123,650 | 123,650 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Philip Nickson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 70,600 | 70,600 | - | - | Stock Option (Right to Buy) |